Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation

Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation. Jacquet, A., Francois, H., Frangie, C., Ahmad, L., Charpentier, B., & Durrbach, A. Transpl Immunol, 20(1-2):29–31, November, 2008.

Paper abstract bibtex

Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.

@article{jacquet_prevention_2008,
	title = {Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation},
	volume = {20},
	issn = {0966-3274 (PRINT) 0966-3274 (LINKING)},
	shorttitle = {Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/18817870},
	abstract = {Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.},
	number = {1-2},
	journal = {Transpl Immunol},
	author = {Jacquet, A. and Francois, H. and Frangie, C. and Ahmad, L. and Charpentier, B. and Durrbach, A.},
	month = nov,
	year = {2008},
	keywords = {Antibodies},
	pages = {29--31},
}

Downloads: 0

{"_id":"JmBKTYf3ydE2SickB","bibbaseid":"jacquet-francois-frangie-ahmad-charpentier-durrbach-preventionofcalcineurininhibitornephrotoxicityinrenaltransplantation-2008","author_short":["Jacquet, A.","Francois, H.","Frangie, C.","Ahmad, L.","Charpentier, B.","Durrbach, A."],"bibdata":{"bibtype":"article","type":"article","title":"Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation","volume":"20","issn":"0966-3274 (PRINT) 0966-3274 (LINKING)","shorttitle":"Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation","url":"http://www.ncbi.nlm.nih.gov/pubmed/18817870","abstract":"Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.","number":"1-2","journal":"Transpl Immunol","author":[{"propositions":[],"lastnames":["Jacquet"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Francois"],"firstnames":["H."],"suffixes":[]},{"propositions":[],"lastnames":["Frangie"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Ahmad"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Charpentier"],"firstnames":["B."],"suffixes":[]},{"propositions":[],"lastnames":["Durrbach"],"firstnames":["A."],"suffixes":[]}],"month":"November","year":"2008","keywords":"Antibodies","pages":"29–31","bibtex":"@article{jacquet_prevention_2008,\n\ttitle = {Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation},\n\tvolume = {20},\n\tissn = {0966-3274 (PRINT) 0966-3274 (LINKING)},\n\tshorttitle = {Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation},\n\turl = {http://www.ncbi.nlm.nih.gov/pubmed/18817870},\n\tabstract = {Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.},\n\tnumber = {1-2},\n\tjournal = {Transpl Immunol},\n\tauthor = {Jacquet, A. and Francois, H. and Frangie, C. and Ahmad, L. and Charpentier, B. and Durrbach, A.},\n\tmonth = nov,\n\tyear = {2008},\n\tkeywords = {Antibodies},\n\tpages = {29--31},\n}\n\n\n\n","author_short":["Jacquet, A.","Francois, H.","Frangie, C.","Ahmad, L.","Charpentier, B.","Durrbach, A."],"key":"jacquet_prevention_2008","id":"jacquet_prevention_2008","bibbaseid":"jacquet-francois-frangie-ahmad-charpentier-durrbach-preventionofcalcineurininhibitornephrotoxicityinrenaltransplantation-2008","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/18817870"},"keyword":["Antibodies"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"http://bibbase.org/zotero/biblioial","dataSources":["ftoP3zPyb2N3b9Noc"],"keywords":["antibodies"],"search_terms":["prevention","calcineurin","inhibitor","nephrotoxicity","renal","transplantation","jacquet","francois","frangie","ahmad","charpentier","durrbach"],"title":"Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation","year":2008}